Advertisement

Behavioral Health

Behavioral healthcare M&A activity climbed in 2025, and transactions in 2026 suggest continuing activity across the sector.  Deal volume rose more than 42% in 2025 with 104 publicly announced transactions, compared to 73 in 2024 and 83 in 2023. Here…

The FDA has approved Teva Pharmaceuticals’ Weltruza (olanzapine) for extended-release injectable suspension to treat schizophrenia in adults. Weltruza is the first and only once-monthly subcutaneous long-acting injectable formulation of olanzapine, according to an Oct. 9 news release. The treatment requires…

Behavioral healthcare providers and systems are increasingly turning to partnerships with the goal of expanding access to mental health and substance use disorder services amid rising demand and workforce shortages.  Here are 10 to know: 1. URAC and The Kennedy…

Advertisement

Behavioral health leaders are tracking three substances this fall, each raising its own set of clinical and operational questions. A potent new synthetic opioid is complicating overdose response protocols, a common prescription drug class is seeing an uptick in exactly…

King of Prussia, Pa.-based Universal Health Services opened Three Trails Behavioral Hospital, a 120-bed behavioral health facility in Independence, Mo. The 88,000-square-foot hospital will provide inpatient treatment, partial hospitalization and intensive outpatient programs for children, adolescents, adults and seniors, according…

The FDA held a public hearing Sept. 14 on the potential future therapeutic use of psychedelic drugs, gathering input on issues that could shape how health systems eventually deliver this care, from provider credentialing to patient safety protocols. Here are…

The healthcare industry is marking 25 years since the Sept. 11, 2001, terrorist attacks by remembering the lives lost that day and the healthcare workers and first responders who answered the call without hesitation. Nearly 3,000 people died in the…

Advertisement